Introduction

If you've tried antidepressants, therapy or other treatments and still feel depressed, you're not alone.

Many people begin to wonder whether they'll ever recover. They may question whether they've been misdiagnosed, whether they've "run out" of treatment options or whether they'll have to live with depression forever.

Those feelings are understandable, but they aren't the whole story.

Treatment-resistant depression (TRD) doesn't mean depression is untreatable. It simply means previous treatments haven't led to sufficient improvement. In many cases, it signals that it's time to take a broader look at the factors contributing to depression and to develop a more personalised treatment plan.

At Hinterland, we believe that when depression doesn't respond as expected, the answer isn't always "more of the same." It's often a reason to ask different questions, reassess the whole person and consider whether important pieces of the puzzle have been overlooked.

What Is Treatment-Resistant Depression?

One of the biggest misconceptions about treatment-resistant depression is that it describes a specific type of depression.

It doesn't.

Instead, it describes how a person's depression has responded to treatment.

In clinical practice, treatment-resistant depression generally refers to depression that has not improved after trying at least two different antidepressant medications, taken at appropriate doses for an adequate length of time.

However, this definition has limitations.

It doesn't consider whether:

• the original diagnosis was correct

• medication was tolerated

• psychological therapy occurred alongside medication

• trauma remained untreated

• sleep disorders were present

• nutrition or metabolic health were contributing

• chronic stress continued

• substance use influenced symptoms

• another medical condition was involved

In other words, "treatment-resistant" may simply mean that the treatment plan hasn't yet addressed the factors driving the depression.

That distinction is important because it shifts the focus from labelling the person to understanding their unique circumstances.

Why Doesn't Depression Respond to Treatment?

When depression persists despite treatment, it's natural to wonder why.

The answer is often more complex than people expect.

Rather than assuming that someone has an untreatable form of depression, clinicians should step back and ask a series of important questions.

Was the diagnosis correct?

Several conditions can resemble depression or occur alongside it, including bipolar disorder, anxiety disorders, post-traumatic stress disorder (PTSD), ADHD, personality disorders, grief and certain medical conditions.

If the diagnosis changes, the treatment approach often changes as well.

Has trauma been fully addressed?

For some people, depression develops in the context of unresolved trauma.

If trauma remains untreated, depression may persist despite medication.

Therapies such as EMDR, trauma-informed CBT or other evidence-based approaches may become important components of recovery.

Could physical health be contributing?

Depression can be influenced by thyroid disorders, chronic pain, sleep apnoea, hormonal changes, vitamin deficiencies, neurological conditions and some medications.

A comprehensive medical review helps identify these possibilities.

Are sleep and lifestyle playing a role?

Sleep disturbance isn't just a symptom of depression, it can also maintain or worsen it.

Similarly, physical inactivity, chronic stress, alcohol use, poor nutrition and social isolation may all influence recovery.

Could nutrition or metabolic health matter?

Growing research suggests that inflammation, insulin resistance, mitochondrial health and the gut-brain axis may influence depression in some people.

While these factors don't explain every case, considering nutritional and metabolic health may help identify additional opportunities to support recovery.

This is one reason why Hinterland includes nutritional and metabolic psychiatry within its whole-person model of care.

How Is Treatment-Resistant Depression Assessed?

When someone has tried multiple treatments without experiencing significant improvement, the most important question is often not, "What's the next medication?" It's "Have we fully understood what's contributing to this person's depression?"

Treatment-resistant depression deserves a fresh assessment rather than simply repeating previous approaches. Depression is a complex condition, and there are many reasons why treatment may not have produced the desired outcome.

A comprehensive reassessment helps identify factors that may have been overlooked and ensures that future treatment is based on the person's current needs rather than assumptions made months or years earlier.

Looking Beyond Symptoms

A thorough assessment considers much more than whether someone still feels depressed. It aims to understand the biological, psychological, social and lifestyle factors that may be influencing both the illness and the person's response to previous treatments.

This may include reviewing:

• Previous diagnoses and treatment history.

• Medications that have been tried, including dose, duration and side effects.

• Psychological therapies undertaken and how they were experienced.

• Trauma history and significant life events.

• Sleep quality and possible sleep disorders.

• Physical health conditions and current medications.

• Alcohol or substance use.

• Nutrition, metabolic health and lifestyle factors.

• Family history of mental illness.

• Relationships, work, social supports and current stressors.

By building a more complete picture, clinicians can identify opportunities to tailor treatment rather than simply adding another intervention.

Reconsidering the Diagnosis

One of the most valuable parts of a comprehensive reassessment is confirming that the original diagnosis remains the most accurate explanation for a person's symptoms.

Several conditions can present with symptoms that overlap with depression or commonly occur alongside it. These include bipolar disorder, anxiety disorders, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), attention-deficit/hyperactivity disorder (ADHD), persistent grief, personality disorders and certain neurological or medical conditions.

In some cases, depression may not be the primary condition. In others, it may exist alongside another diagnosis that also requires treatment. Identifying these factors can significantly influence the direction of care.

Identifying Contributing Physical Health Factors

Mental and physical health are closely connected. When depression persists, it is important to consider whether underlying medical conditions may be contributing to symptoms.

Depending on the individual's circumstances, clinicians may investigate factors such as:

• Thyroid disorders.

• Hormonal changes.

• Chronic pain.

• Sleep apnoea.

• Vitamin and mineral deficiencies.

• Cardiovascular or neurological conditions.

• Medication side effects.

• Chronic inflammation or metabolic dysfunction.

Addressing these issues doesn't replace evidence-based mental health treatment, but it can remove barriers that may be making recovery more difficult.

Understanding Brain Function

At Hinterland, comprehensive psychiatric assessment remains the cornerstone of understanding depression. Where clinically appropriate, this assessment may be complemented by quantitative electroencephalography (qEEG) brain mapping and biometric measures.

A qEEG records patterns of electrical activity in the brain, providing additional information that may assist clinicians in understanding brain function. It is not used to diagnose treatment-resistant depression, nor can it determine whether someone will respond to a particular treatment. Instead, it contributes one piece of a much broader clinical picture.

Where appropriate, qEEG and biometric assessments are performed at the beginning of treatment to establish an objective baseline. These measures may be repeated later in a guest's programme to observe changes over time alongside validated symptom questionnaires, clinical assessment and improvements in day-to-day functioning.

Technology is never a substitute for clinical expertise. Rather, it complements the knowledge and experience of the multidisciplinary team, supporting more informed and personalised treatment planning.

Evidence-Based Treatments for Treatment-Resistant Depression

Receiving a diagnosis of treatment-resistant depression does not mean that effective treatments have been exhausted.

In fact, many people who meet the criteria for treatment-resistant depression improve after their treatment plan is reviewed and individualised. The key is identifying which combination of therapies is most likely to address the factors contributing to their depression.

Rather than relying on a single intervention, current best practice often involves combining several evidence-based approaches within a coordinated treatment plan.

Optimising Existing Treatment

Sometimes, improvement comes not from introducing an entirely new treatment but from optimising what is already in place.

This may involve:

• Reviewing current medications.

• Adjusting the dose or timing of treatment.

• Changing to a different antidepressant where appropriate.

• Considering evidence-based augmentation strategies under psychiatric supervision.

• Reassessing psychological therapy goals.

• Addressing barriers such as poor sleep or ongoing stress.

A careful review helps ensure that previous treatments have been given the best opportunity to work before concluding they have been unsuccessful.

Personalised Psychological Therapy

When depression has persisted despite previous treatment, psychological therapy often benefits from a fresh perspective rather than simply repeating familiar strategies.

Different therapeutic approaches may be appropriate depending on the individual's history, symptoms and contributing factors. For example, someone whose depression is closely linked to unresolved trauma may benefit from a different approach than someone whose symptoms are driven primarily by chronic self-criticism, perfectionism or emotional avoidance.

At Hinterland, psychologists tailor therapy using a range of evidence-based modalities, including Cognitive Behavioural Therapy (CBT), Acceptance and Commitment Therapy (ACT), Eye Movement Desensitisation and Reprocessing (EMDR), Dialectical Behaviour Therapy (DBT), Schema Therapy, Internal Family Systems (IFS), Mindfulness-Based Cognitive Therapy (MBCT), Gestalt Therapy, Somatic Therapy and Emotional Freedom Techniques (EFT).

Rather than asking people to fit a particular therapeutic model, we tailor therapy to the individual and adapt it as recovery progresses.

Internal Link → Types of Therapy for Depression: CBT, ACT, EMDR and More Compared

Why a Multidisciplinary Approach Matters

People living with treatment-resistant depression have often worked incredibly hard to get better. They may have seen multiple healthcare providers, tried different medications, attended therapy and made lifestyle changes, yet still feel as though they're managing their recovery alone.

One of the challenges in traditional healthcare is that treatment is often fragmented.

A GP may prescribe medication. A psychologist focuses on therapy. A psychiatrist reviews medication every few months. A dietitian provides nutritional advice. An exercise physiologist develops a movement programme. Each clinician may provide excellent care, but they often work independently, with limited opportunity to collaborate or develop a shared treatment plan.

For someone with a straightforward episode of depression, this approach may be sufficient. However, when depression has persisted despite previous treatment, a more integrated model of care can be valuable.

At Hinterland, we believe treatment-resistant depression benefits from a team approach.

Our psychiatrists, psychologists and allied health professionals work together to develop a personalised treatment plan, regularly reviewing each guest's progress and sharing insights from their respective disciplines. Rather than viewing depression through a single lens, we consider how biological, psychological, social and lifestyle factors interact to influence recovery.

This collaborative approach helps ensure that treatment is coordinated, consistent and responsive as a person's needs evolve.

Most importantly, guests don't have to coordinate their own care. The treating team works together, allowing guests to focus on what matters most, recovery.

The Hinterland Foundations for Whole-Person Recovery

Treatment-resistant depression rarely has a single cause, and it rarely responds to a single solution.

For some people, unresolved trauma may be a significant contributor. For others, disrupted sleep, chronic stress, physical health conditions, social isolation or metabolic health may play a more prominent role. Often, several factors interact, making recovery more complex than simply changing a medication or attending more therapy sessions.

At Hinterland, our approach is guided by six interconnected foundations that recognise the complexity of depression and the individuality of every person we care for.

1. Care

Every recovery journey begins with feeling genuinely cared for.

While clinical expertise and evidence-based treatments are essential, research consistently shows that the quality of the therapeutic relationship is one of the strongest predictors of positive mental health outcomes.

When people feel heard, respected and psychologically safe, they are often more willing to engage in treatment, explore difficult experiences and embrace meaningful change.

Many of our guests tell us that, after years of navigating the mental health system, one of the most significant differences they noticed at Hinterland was the feeling that they were truly seen as a person, not simply as a diagnosis.

That sense of trust forms the foundation for everything that follows.

2. Mind

There is no single psychological therapy that works for everyone experiencing treatment-resistant depression.

Some people benefit from learning practical strategies to challenge unhelpful thinking patterns. Others need support to process trauma, develop emotional regulation skills or understand long-standing beliefs that continue to shape their lives.

Our psychologists tailor therapy using a range of evidence-based approaches, including Cognitive Behavioural Therapy (CBT), Acceptance and Commitment Therapy (ACT), Eye Movement Desensitisation and Reprocessing (EMDR), Dialectical Behaviour Therapy (DBT), Schema Therapy, Internal Family Systems (IFS), Compassion Focused Therapy (CFT), Mindfulness-Based Cognitive Therapy (MBCT), Gestalt Therapy, Somatic Therapy and Emotional Freedom Techniques (EFT).

Rather than asking people to fit a particular therapy, we tailor therapy to fit the individual.

Internal Link → Types of Therapy for Depression: CBT, ACT, EMDR and More Compared

3. Brain

Understanding brain health is an important part of understanding depression.

Psychiatric assessment remains central to treatment planning, helping identify factors such as medication response, co-occurring mental health conditions and the overall clinical picture.

Where clinically appropriate, this assessment may be complemented by quantitative electroencephalography (qEEG) brain mapping and biometric measures. These objective assessments establish a baseline at the beginning of treatment and, where appropriate, may be repeated to help monitor changes alongside symptom improvement, cognitive functioning and clinical assessment.

Rather than replacing clinical expertise, these tools contribute additional information that supports personalised care.

4. Body

Persistent depression often affects the whole body.

Fatigue, disrupted sleep, reduced physical activity and chronic activation of the stress response can all contribute to ongoing symptoms.

Supporting physical wellbeing may include improving sleep habits, encouraging regular movement, regulating the nervous system through breathwork and relaxation techniques, and establishing sustainable daily routines.

These interventions work alongside psychological and psychiatric care to support overall recovery.

5. Nutrition & Metabolic Health

Growing evidence suggests that nutrition and metabolic health may influence brain function and emotional wellbeing.

Research into nutritional psychiatry and metabolic psychiatry has highlighted the potential role of inflammation, insulin resistance, mitochondrial function and the gut-brain axis in some people experiencing depression.

At Hinterland, these factors are considered as part of a comprehensive assessment rather than in isolation. Nutritional and metabolic strategies are integrated into a broader treatment plan that also includes psychiatry, psychology and lifestyle medicine.

6. Purpose, Connection & Spirit

Treatment-resistant depression often erodes more than mood. It can leave people feeling disconnected from themselves, from others and from the things that once gave life meaning.

Recovery involves more than reducing symptoms. It also means rebuilding hope, reconnecting with personal values and rediscovering a sense of purpose.

For some people, this begins by strengthening relationships with family and friends. For others, it involves reconnecting with creativity, spending time in nature, contributing to their community or exploring spiritual wellbeing in ways that align with their own beliefs and values.

Whatever form it takes, restoring purpose, connection and hope is an important part of building a life beyond depression.

New and Emerging Treatments for Treatment-Resistant Depression

Research into treatment-resistant depression continues to evolve, and in recent years several innovative therapies have generated significant interest among clinicians, researchers and people seeking alternatives after conventional treatments have been unsuccessful.

For some individuals, these newer treatments may offer additional options. However, it is important to recognise that no single therapy is effective for everyone, and even the most promising interventions work best when they are part of a comprehensive, personalised treatment plan.

At Hinterland, we closely follow advances in mental health research while remaining committed to evidence-based practice. We believe innovation is important, but it should complement, not replace, a thorough assessment, multidisciplinary care and an understanding of the whole person.

Ketamine-Assisted Therapy

Ketamine has become one of the most significant advances in the treatment of treatment-resistant depression over the past two decades.

Unlike traditional antidepressants, which often take several weeks to produce noticeable improvements, ketamine may reduce depressive symptoms much more rapidly for some people. This has made it an important option for carefully selected individuals whose depression has not responded to conventional treatments.

In Australia, ketamine therapy is available in selected specialist settings and requires careful psychiatric assessment, ongoing medical supervision and structured follow-up. While many people experience meaningful improvements, ketamine is not appropriate for everyone, and it should always be considered within the context of a broader treatment plan rather than as a standalone solution.

Psychedelic-Assisted Therapy

Psychedelic-assisted therapy, particularly using psilocybin, has received considerable attention following encouraging results from early clinical trials involving people with treatment-resistant depression.

Research suggests that, when delivered within carefully structured therapeutic programmes, psilocybin may help some people experience significant reductions in depressive symptoms. However, these treatments remain highly specialised and continue to be evaluated through ongoing clinical research.

As our understanding grows, psychedelic-assisted therapies may become an increasingly important option for selected individuals, but they are not suitable for everyone and require careful assessment by experienced clinicians.

Ibogaine

Another treatment attracting international interest is ibogaine, a naturally occurring psychoactive compound derived from the Tabernanthe iboga plant, native to Central West Africa.

Historically, ibogaine has been used in traditional spiritual ceremonies. More recently, a small number of specialist clinics overseas have begun exploring its potential role in treating substance use disorders and, in some cases, treatment-resistant depression. While anecdotal reports and early observational research have suggested possible benefits for some individuals, the scientific evidence remains limited.

Unlike ketamine, ibogaine has not yet been established as an evidence-based treatment for depression. It is associated with potentially serious medical risks, including disturbances of heart rhythm and other cardiovascular complications, meaning it should only ever be administered in specialist medical settings with comprehensive screening and monitoring.

Further high-quality clinical trials are needed before ibogaine can be considered a routine treatment option for depression.

Looking Beyond Individual Treatments

While innovative therapies continue to expand the possibilities for treating depression, they are only one part of the picture.

For many people living with treatment-resistant depression, the greatest breakthrough doesn't come from discovering a single new treatment. It comes from taking a step back and asking whether every factor contributing to their depression has been fully understood.

Has the diagnosis been reviewed?

Has unresolved trauma been addressed?

Could sleep, nutrition, metabolic health or chronic stress be influencing recovery?

Are psychological, psychiatric and lifestyle interventions working together towards the same goals?

These questions often prove just as important as deciding which treatment to try next.

At Hinterland, we believe the most effective care combines evidence-based psychiatry, personalised psychological therapy, lifestyle medicine, nutritional and metabolic health, objective assessment where clinically appropriate and the collaborative expertise of a multidisciplinary team. New and emerging treatments may play an important role for some individuals, but they should always be considered within the context of comprehensive, whole-person care.

Ultimately, our goal isn't simply to find another treatment. It's to understand the individual sitting in front of us and develop the treatment plan that gives them the best opportunity to recover.

Recovery Is Still Possible

Hearing the words "treatment-resistant depression" can be frightening. Many people interpret the diagnosis as meaning that nothing will work or that they have reached the end of available treatment options.

Fortunately, that isn't what the term means.

Treatment-resistant depression simply describes how your depression has responded to previous treatments. It does not define your future, and it does not mean recovery is out of reach.

For many people, the next stage of recovery begins not with trying another medication, but with asking better questions.

Has every contributing factor been explored?

Has the diagnosis been reviewed?

Has trauma been fully addressed?

Are physical health, sleep, nutrition and metabolic health influencing symptoms?

Has treatment been truly integrated, or have different aspects of care been delivered in isolation?

Sometimes, answering these questions reveals opportunities that had previously been overlooked. Sometimes, it leads to a different therapeutic approach. Sometimes, it confirms that recovery requires time, persistence and a coordinated team working towards the same goals.

There is rarely a single breakthrough that changes everything overnight. More often, recovery happens through a series of carefully considered steps that gradually restore hope, resilience and quality of life.

A Different Way of Thinking About Recovery

At Hinterland, we don't see treatment-resistant depression as a sign that someone has "failed treatment." Instead, we see it as an opportunity to take a broader, more comprehensive look at what may be keeping that person stuck.

Depression is rarely caused by one factor alone, and lasting recovery rarely comes from a single intervention.

That's why our approach combines compassionate care with evidence-based psychiatry, personalised psychological therapy, lifestyle medicine, nutritional and metabolic health, objective assessment where clinically appropriate, and the expertise of a collaborative multidisciplinary team.

Rather than asking, "What treatment should we try next?", we ask:

• What has this person already experienced?

• What factors may have been overlooked?

• What strengths can we build upon?

• What combination of treatments is most likely to help this individual recover?

These questions reflect our belief that effective treatment begins with understanding the whole person, not just the diagnosis.

There Is Always Reason for Hope

One of the most important things we want people to take away from this article is that treatment-resistant depression is not the end of the road.

Every year, people who have struggled with depression for months, or even years, find meaningful improvement after receiving a more personalised, integrated approach to care. While recovery is rarely linear, progress is possible, even after previous treatments have been disappointing.

Hope doesn't come from pretending depression is simple. It comes from recognising that depression is complex, and that treatment should be too.

With the right assessment, the right support and the right team, many people rediscover the things depression has taken from them: energy, confidence, connection, purpose and joy.

Recovery may not happen overnight, but it is possible.

Looking for Support?

If you or someone you care about is living with treatment-resistant depression, seeking a comprehensive assessment can be an important next step. Whether you're exploring treatment for the first time or looking for a fresh perspective after previous treatments haven't worked, understanding the whole picture can help guide more personalised care.

To learn more about Hinterland's approach to depression treatment, explore our Residential Depression Treatment Programme or speak with our team about whether our multidisciplinary model of care may be right for you.

Internal Links:

• Depression Treatment Programme

• Types of Therapy for Depression

• Clinical Depression: Symptoms, Causes and Treatments

• Treating Depression and Anxiety Together

• Natural Treatments for Depression

• Contact Hinterland

Medical Disclaimer: This article is intended for general educational purposes only and should not be considered medical advice, diagnosis or treatment. Every person's experience of depression is different, and treatment should always be tailored to individual needs. If you're concerned about your mental health, speak with your GP, psychologist, psychiatrist or another qualified healthcare professional. If you or someone you know is in immediate danger or experiencing a mental health crisis, call 000 or present to your nearest emergency department. You can also contact Lifeline Australia on 13 11 14 for 24-hour crisis support.